Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis

Arthritis and Rheumatism

Volumn 64, Issue 12, 2012, Pages 4135-4142

  Bennett, Tellen D ^a   Fluchel, Mark ^a   Hersh, Aimee O ^a   Hayward, Kristen N ^b   Hersh, Adam L ^a   Brogan, Thomas V ^b   Srivastava, Rajendu ^a   Stone, Bryan L ^a   Korgenski, E Kent ^a   Mundorff, Michael B ^c   Casper, T Charles ^a   Bratton, Susan L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; ETOPOSIDE; HYDROCORTISONE; HYPERTENSIVE AGENT; IMMUNOGLOBULIN; INOTROPIC AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MANNITOL; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRIC OXIDE; RITUXIMAB; SODIUM CHLORIDE;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS RENAL REPLACEMENT THERAPY; DIALYSIS; ELECTROENCEPHALOGRAM; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; HYPONATREMIA; INFANT; INTENSIVE CARE UNIT; JUVENILE RHEUMATOID ARTHRITIS; MACROPHAGE ACTIVATION SYNDROME; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROIMAGING; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PEDIATRICS; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYCLOPHOSPHAMIDE; CYCLOSPORINE; FEMALE; HOSPITAL MORTALITY; HUMANS; INFANT; INFANT, NEWBORN; INPATIENTS; INTENSIVE CARE UNITS, PEDIATRIC; INTERLEUKIN-1; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGE ACTIVATION SYNDROME; MALE; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84870331620     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34661     Document Type: Article

References (27)

1. Janka G,. Hemophagocytic syndromes. Blood Rev 2007; 21: 245-53. (Pubitemid 47212601)
2. Henter J, Horne A, Arico M, Egeler R, Filipovich A, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-31. (Pubitemid 44958267)
3. Stephan J, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur A,. Reactive haemophagocytic syndrome in children with inflammatory disorders: a retrospective study of 24 patients. Rheumatology (Oxford) 2001; 40: 1285-92.
4. Sawhney S, Woo P, Murray K,. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001; 85: 421-6. (Pubitemid 33702300)
5. Kelly C, Salvi S, McClain K, Hayani A,. Hemophagocytic lymphohistiocytosis associated with precursor B acute lymphoblastic leukemia. Pediatr Blood Cancer 2011; 56: 658-60.
6. Pringe A, Trail L, Ruperto N, Buoncompagni A, Loy A, Breda L, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication? Lupus 2007; 16: 587-92. (Pubitemid 47359993)
7. Parodi A, Davi S, Pringe AB, Pistorio A, Ruperto N, Magni-Manzoni S, et al, for the Lupus Working Group of the Paediatric Rheumatology European Society. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 2009; 60: 3388-99.
8. Grom A,. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol 2003; 15: 587-90. (Pubitemid 37041397)
9. Zeft A, Hollister R, LaFleur B, Sampath P, Soep J, McNally B, et al. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience. J Clin Rheumatol 2009; 15: 161-4.
10. Son MB, Gauvreau K, Ma L, Baker AL, Sundel RP, Fulton DR, et al. Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics 2009; 124: 1-8.
11. Weiss PF, Klink AJ, Hexem K, Burnham JM, Leonard MB, Keren R, et al. Variation in inpatient therapy and diagnostic evaluation of children with Henoch Schonlein purpura. J Pediatr 2009; 155: 812-18.e1.
12. Weiss PF, Klink AJ, Localio R, Hall M, Hexem K, Burnham JM, et al. Corticosteroids may improve clinical outcomes during hospitalization for Henoch-Schonlein purpura. Pediatrics 2010; 126: 674-81.
13. Child Health Corporation of America. URL: http://www.chca.com/index-no- flash.html.
14. Conway PH, Keren R,. Factors associated with variability in outcomes for children hospitalized with urinary tract infection. J Pediatr 2009; 154: 789-96.
15. Goldin AB, Sawin RS, Garrison MM, Zerr DM, Christakis DA,. Aminoglycoside-based triple-antibiotic therapy versus monotherapy for children with ruptured appendicitis. Pediatrics 2007; 119: 905-11. (Pubitemid 46715660)
16. Turney CM, Wang W, Seiber E, Lo W,. Acute pediatric stroke: contributors to institutional cost. Stroke 2011; 42: 3219-25.
17. Hickey PW, Cape KE, Masuoka P, Campos JM, Pastor W, Wong EC, et al. A local, regional, and national assessment of pediatric malaria in the United States. J Travel Med 2011; 18: 153-60.
18. National Center for Health Statistics and the Centers for Medicare and Medicaid Services. Conversion Table of New ICD-9-CM Codes, October 2011. URL http://www.cdc.gov/nchs/data/icd9/CNVTB12.pdf.
19. Gupta AA, Tyrrell P, Valani R, Benseler S, Abdelhaleem M, Weitzman S,. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution. J Pediatr Hematol Oncol 2009; 31: 81-4.
20. Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005; 146: 598-604. (Pubitemid 40616243)
21. Yamazawa K, Kodo K, Maeda J, Omori S, Hida M, Mori T, et al. Hyponatremia, hypophosphatemia, and hypouricemia in a girl with macrophage activation syndrome. Pediatrics 2006; 118: 2557-60. (Pubitemid 46397601)
22. Bruck N, Suttorp M, Kabus M, Heubner G, Gahr M, Pessler F,. Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids. J Clin Rheumatol 2011; 17: 23-7.
23. Kumar S, Vaidyanathan B, Gayathri S, Rajam L,. Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review. Rheumatol Int 2010. E-pub ahead of print.
24. Fall N, Barnes M, Thornton S, Luyrink L, Olson J, Ilowite NT, et al. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum 2007; 56: 3793-804. (Pubitemid 350100712)
25. Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor α-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007; 56: 965-71. (Pubitemid 46399444)
26. Behrens EM, Beukelman T, Paessler M, Cron RQ,. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 2007; 34: 1133-8. (Pubitemid 46774861)
27. Keren R, Wheeler A, Coffin SE, Zaoutis T, Hodinka R, Heydon K,. ICD-9 codes for identifying influenza hospitalizations in children. Emerg Infect Dis 2006; 12: 1603-4. (Pubitemid 44570911)